Please login to the form below
Spirogen
This page shows the latest Spirogen news and features for those working in and with pharma, biotech and healthcare.
MedImmune partners with US National Cancer Institute
AZ boosted its pipeline in thsi area with the $440m acquisition of Spirogen.
Latest news
-
MedImmune partners with US National Cancer Institute
AZ boosted its pipeline in thsi area with the $440m acquisition of Spirogen.
-
MPs grill Read over Pfizer's commitments to UK
with a move away from commercial-led megamergers and a shift towards small- and mid-scale, science-led acquisitions such as its recent purchase of Spirogen.
-
Soriot says pipeline will speed recovery at AZ
Last year it bought respiratory company Pearl Therapeutics in a $1.15bn deal as well as biopharma companies AlphaCore Pharma, Spirogen, Amplimmune and Omthera Pharmaceuticals.
-
2013 - biotech boomed
AZ's 2013 deal-making spree also saw it acquire Amplimmune, a Maryland, US-based biotech with a number of early-stage cancer projects, and UK firm Spirogen, which develops ... Financial details of the AlphaCore deal were not released, but AZ's
-
AZ said to be eyeing Forest takeover bid
Last month the company agreed to pay $440m to buy antibody-drug conjugate (ADC) specialist Spirogen, while in August it bought cancer company Amplimmune in a deal valued at up to
More from news
Approximately 1 fully matching, plus 8 partially matching documents found.
Latest Intelligence
-
Pharma deals during October 2013
Auven's portfolio of companies includes Resolvyx, Kiacta, Kolitan and Sprout Pharmaceuticals, as well as Spirogen and ADC Therapeutics. ... The Spirogen/Auven Therapeutics deal with MedImmune discussed above re-confirms that ADC technology is certainly
-
Deal Watch table for October 2013
730. Spirogen / MedImmune. Acquisition. ADC technology - oncology (lead asset in phase II).
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Business Unit Head, Medical Communications, London
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
Subscribe to our email news alerts
- Moving annual total (MAT)
- Brexit rebels win vote on European Medicines Agency alignment
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- MaxCyte gets green light for solid tumour cell therapy
- NHS England to Vertex: come clean on Orkambi offer
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Ashfield
Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
